Stock Price

New US tax rules have fundamentally changed the economics of software development: domestic engineers and AI hardware are now fully deductible in year one, while offshore talent costs must be amortized over 15 years. This report details how the resulting "tax wedge" is dismantling the traditional offshoring model and driving a strategic shift toward re-onshoring and automation.

FOX News Media's new 90-second 'FOX News Report' with Bill Melugin aims to blend national news into local broadcasts, a strategic multiplatform play.

After a challenging 2025, Lennox sets the stage for its March 4 Investor Day, where it will reveal new long-term growth targets to a watchful market.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

Cresud reports a massive profit swing, but a closer look reveals non-cash real estate gains masking a dip in operational earnings from its core farm business.

Fresh off a strategic rebrand and a record-breaking year, Potomac Bancshares is courting investors and cementing its role as a Mid-Atlantic banking leader.

NEXGEL has financing for a major acquisition, but the deal hinges on a critical due diligence phase. What does this mean for the hydrogel innovator?

Celularity Inc. has secured a $12.2M cash injection by selling tax losses, a move set to accelerate its cutting-edge longevity and regenerative medicine pipeline.

After a stellar 2025, Corpay is hitting the road for key investor conferences. Can it convince the market its impressive growth is just the beginning?

In a major market shakeup, Dingdong is selling its China grocery operations to rival Meituan and plans to return the proceeds to shareholders.

After a stock plunge, Yext offers to buy back shares at a premium, signaling deep undervaluation and creating a critical choice for its investors.

The financial services firm posted lower delinquency and loss rates for January, but is it a sign of a healthier consumer or savvy internal strategy?

The drive-thru coffee giant is moving into your kitchen, taking on Starbucks and Nestlé with its new retail line. But can its 'Dutch Luv' succeed on shelves?

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

The advanced nuclear startup's new funding and partnership with Blue Owl signal a major push to solve the massive energy demands of data centers.

Cloud communications firm RingCentral will join the S&P SmallCap 600, triggering investment shifts and highlighting tech's growing market influence.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

The BDC generated a robust 12.52% yield, but a $7.2M unrealized loss in equities pulled down its net asset value, painting a complex picture.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.